Capricor Company

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a clinical-stage biotechnology company focused on the development of cell and exosome-based therapeutics for the treatment and prevention of serious diseases.
Industry: Loss of Proteostasis
Headquarters: United States
Visit Website
Register and Claim Ownership